NCT07364331 Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)
| NCT ID | NCT07364331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-09-04 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2021-09-04 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Eligibility Criteria
Inclusion Criteria: 1. DSM-5 diagnosis of ADHD 2. Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial. 3. SNAP-IV inattention subscale \>=12, or hyperactivity subscale \>=12, or inattention+ hyperactivity subscales \>=24 Exclusion Criteria: 1. IQ\<80 2. Allergic to omega-3 3. Physical disorders: thyroid function, cancer 4. Psychiatric comorbidity: SUD, psychotic disorders, bipolar disorder, major depressive disorder
Contact & Investigator
Pei-Chen Chang, PhD
PRINCIPAL INVESTIGATOR
China Medical University Hospital
Frequently Asked Questions
Who can join the NCT07364331 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07364331 currently recruiting?
Yes, NCT07364331 is actively recruiting participants. Contact the research team at 013121@tool.caaumed.org.tw for enrollment information.
Where is the NCT07364331 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07364331 clinical trial?
NCT07364331 is sponsored by China Medical University Hospital. The principal investigator is Pei-Chen Chang, PhD at China Medical University Hospital. The trial plans to enroll 100 participants.